Giulia Negrini

Bologna, 40138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods.

Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods.

Journal: Nutrients

Published: June 30, 2022

Current guidelines for the management of celiac disease: A systematic review with comparative analysis.

Current guidelines for the management of celiac disease: A systematic review with comparative analysis.

Journal: World journal of gastroenterology

Published: March 02, 2021

Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients.

Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients.

Journal: Journal of hepatology

Published: April 24, 2019

Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis.

Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis.

Journal: Nutrients

Published: November 08, 2018

Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors.

Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors.

Journal: Alimentary pharmacology & therapeutics

Published: March 27, 2018

Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.

Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.

Journal: European radiology

Published: December 29, 2017

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives.

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives.

Journal: Hepatic oncology

Published: September 04, 2017

Long term effects of gluten-free diet in non-celiac wheat sensitivity.

Long term effects of gluten-free diet in non-celiac wheat sensitivity.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: August 22, 2017

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 03, 2017

A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease.

A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease.

Journal: International journal of molecular sciences

Published: April 20, 2017

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.

Journal: Journal of hepatology

Published: November 14, 2016

Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Journal: Therapeutic advances in gastroenterology

Published: March 02, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026